Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes.

Altun I, Güneş Kaya D, Uçar M, Gözderesi Y, Haşlak GV, Karakaş H, Bayramoğlu E, Evliyaoglu O, Turan H

DOI: 10.1186/s12902-026-02279-x
Published: 2026 Apr 17
Container: BMC endocrine disorders
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12902-026-02279-x,
  title = {Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes.},
  author = {Altun I and Güneş Kaya D and Uçar M and Gözderesi Y and Haşlak GV and Karakaş H and Bayramoğlu E and Evliyaoglu O and Turan H},
  year = {2026},
  journal = {BMC endocrine disorders},
  doi = {10.1186/s12902-026-02279-x},
  url = {https://doi.org/10.1186/s12902-026-02279-x}
}

RIS

TY  - JOUR
TI  - Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes.
AU  - Altun I
AU  - Güneş Kaya D
AU  - Uçar M
AU  - Gözderesi Y
AU  - Haşlak GV
AU  - Karakaş H
AU  - Bayramoğlu E
AU  - Evliyaoglu O
AU  - Turan H
PY  - 2026
JO  - BMC endocrine disorders
DO  - 10.1186/s12902-026-02279-x
UR  - https://doi.org/10.1186/s12902-026-02279-x
ER  -

APA

I, A., D, G. K., M, U., Y, G., GV, H., H, K., E, B., O, E., & H, T. (2026). Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes.. BMC endocrine disorders. https://doi.org/10.1186/s12902-026-02279-x

Source records

pubmed · retrieved 2026-09-25T23:48:47.493Z